These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 19103290)

  • 1. 8-Prenylnaringenin inhibits epidermal growth factor-induced MCF-7 breast cancer cell proliferation by targeting phosphatidylinositol-3-OH kinase activity.
    Brunelli E; Pinton G; Chianale F; Graziani A; Appendino G; Moro L
    J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):163-70. PubMed ID: 19103290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 8-Prenylnaringenin, inhibits estrogen receptor-alpha mediated cell growth and induces apoptosis in MCF-7 breast cancer cells.
    Brunelli E; Minassi A; Appendino G; Moro L
    J Steroid Biochem Mol Biol; 2007; 107(3-5):140-8. PubMed ID: 17681752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
    Mut M; Lule S; Demir O; Kurnaz IA; Vural I
    Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling.
    Weng MS; Ho CT; Ho YS; Lin JK
    Toxicol Appl Pharmacol; 2007 Jan; 218(2):107-18. PubMed ID: 17182072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired resistance to oestrogen deprivation: role for growth factor signalling kinases/oestrogen receptor cross-talk revealed in new MCF-7X model.
    Staka CM; Nicholson RI; Gee JM
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S85-97. PubMed ID: 16113102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The nuclear factor kappa B activation: the key step of cell proliferation in estrogen receptor-negative breast cancer cells].
    Wang HJ; Wu ZY; Fan P; Bian JM
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):1014-6. PubMed ID: 16194364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells.
    Jordan NJ; Gee JM; Barrow D; Wakeling AE; Nicholson RI
    Breast Cancer Res Treat; 2004 Sep; 87(2):167-80. PubMed ID: 15377841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells.
    Jeong YJ; Choi Y; Shin JM; Cho HJ; Kang JH; Park KK; Choe JY; Bae YS; Han SM; Kim CH; Chang HW; Chang YC
    Food Chem Toxicol; 2014 Jun; 68():218-25. PubMed ID: 24675423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells.
    Burdick AD; Davis JW; Liu KJ; Hudson LG; Shi H; Monske ML; Burchiel SW
    Cancer Res; 2003 Nov; 63(22):7825-33. PubMed ID: 14633709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling.
    Varma H; Conrad SE
    Cancer Res; 2002 Jul; 62(14):3985-91. PubMed ID: 12124331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes.
    Dajani OF; Meisdalen K; Guren TK; Aasrum M; Tveteraas IH; Lilleby P; Thoresen GH; Sandnes D; Christoffersen T
    J Cell Physiol; 2008 Feb; 214(2):371-80. PubMed ID: 17654493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin-like growth factor receptor I signaling in a breast cancer cell line].
    Mejía W; Castro C; Umaña A; de Castro C; Riveros T; Sánchez-Gómez M
    Biomedica; 2010; 30(4):551-8. PubMed ID: 21713359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival.
    Coutant A; Rescan C; Gilot D; Loyer P; Guguen-Guillouzo C; Baffet G
    Hepatology; 2002 Nov; 36(5):1079-88. PubMed ID: 12395317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGF-dependent cell cycle progression is controlled by density-dependent regulation of Akt activation.
    LeVea CM; Reeder JE; Mooney RA
    Exp Cell Res; 2004 Jul; 297(1):272-84. PubMed ID: 15194442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytoestrogens in menopausal supplements induce ER-dependent cell proliferation and overcome breast cancer treatment in an in vitro breast cancer model.
    van Duursen MB; Smeets EE; Rijk JC; Nijmeijer SM; van den Berg M
    Toxicol Appl Pharmacol; 2013 Jun; 269(2):132-40. PubMed ID: 23541764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells.
    Hamelers IH; van Schaik RF; van Teeffelen HA; Sussenbach JS; Steenbergh PH
    Exp Cell Res; 2002 Feb; 273(1):107-17. PubMed ID: 11795951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.